J T. Tansey, et.al., Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity., Proceedings of the National Academy of Sciences of the United States of America, 2001, 98

http://rdf.ncbi.nlm.nih.gov/pubmed/11371650

J T. Tansey, et.al., Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity., Proceedings of the National Academy of Sciences of the United States of America, 2001, 98

http://rdf.ncbi.nlm.nih.gov/pubmed/

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD38143
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD38143

allele

http://purl.org/net/cito/citesAsAuthority

• Plin1<tm1Cdl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2176249

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• enhanced lipolysis_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0008034I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased brown fat lipid droplet number_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0009137I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• abnormal glucose homeostasis_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0002078I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• abnormal liver morphology_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0000598I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased total fat pad weight_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0008907I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased subcutaneous adipose tissue amount_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0008844I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• increased lean body mass_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0003960I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased total body fat amount_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0010025I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• impaired lipolysis_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0008033I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased parametrial fat pad weight_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0009301I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• increased circulating insulin level_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0002079I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased epididymal fat pad weight_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0009289I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• increased circulating leptin level_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0005669I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• abnormal lipolysis_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0008032I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• abnormal fat pad morphology_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0005334I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased retroperitoneal fat pad weight_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0009305I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• increased oxygen consumption_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0005289I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• impaired glucose tolerance_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0005293I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl
• decreased inguinal fat pad weight_Plin1<tm1Cdl>/Plin1<tm1Cdl>
  http://metadb.riken.jp/0009293I129S6SvEvTacC57BL6Plin1tm1CdlPlin1tm1CdlPlin1tm1Cdl